Revolution Medicines, Inc. (RVMD) FY2024 Q3 Balance Sheet

Revolution Medicines, Inc. (RVMD) FY2024 Q3 Balance Sheet

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

Assets

1,762,999,000 US dollars

Current assets

1,579,139,000 US dollars

Non-current assets

183,860,000 US dollars

Liabilities

196,695,000 US dollars

Current liabilities

110,863,000 US dollars

Non-current liabilities

85,832,000 US dollars

Equity

1,566,304,000 US dollars

Marketable securities

1,348,219,000 US dollars

Cash and cash equivalents

201,262,000 US dollars

Prepaid expenses and other current assets

29,658,000 US dollars

Accounts receivable

0 US dollars

Operating lease right-of-use asset

74,338,000 US dollars

Intangible assets, net

56,937,000 US dollars

Property and equipment, net

24,814,000 US dollars

Goodwill

14,608,000 US dollars

Other noncurrent assets

10,275,000 US dollars

Restricted cash

2,888,000 US dollars

Accrued expenses and other current liabilities

78,011,000 US dollars

Accounts payable

24,456,000 US dollars

Operating lease liability, current

8,396,000 US dollars

Operating lease liability, noncurrent

78,310,000 US dollars

Deferred tax liability

3,115,000 US dollars

Warrant liabilities

2,763,000 US dollars

Other noncurrent liabilities

1,644,000 US dollars

Additional paid-in capital

3,105,708,000 US dollars

Accumulated other comprehensive income

3,812,000 US dollars

Common stock, $0.0001 par value; 300,000,000 shares authorized as of September 30, 2024 and December 31, 2023, respectively; 173,308,336 and 170,234,594 shares issued as of September 30, 2024 and December 31, 2023, respectively; 167,748,336 and 164,674,594 shares outstanding as of September 30, 2024 and December 31, 2023, respectively

16,000 US dollars

Preferred stock, $0.0001 par value; 10,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively; none issued and outstanding at September 30, 2024 and December 31, 2023, respectively

0 US dollars

Accumulated deficit

negative 1,543,232,000 US dollars

Gross equity (calculated)

3,109,536,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.